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Keratinocytes express high levels of 25OHD 1a-hydroxylase (1OHase). The product of this enzyme, 1,25-
dihydroxyvitamin D (1,25(OH)2D), promotes the differentiation of keratinocytes in vitro suggesting an important role
for this enzyme in epidermal differentiation. To test whether 1OHase activity is essential for keratinocyte
differentiation in vivo we examined the differentiation process in mice null for the expression of the 1aOHase gene
(1aOHase/). Heterozygotes for the null allele were bred, and the progeny genotyped by PCR. The epidermis of the
1aOHase/ animals and their wild-type littermates (1aOHaseþ /þ ) were examined by histology at the light and
electron microscopic level, by immunocytochemistry for markers of differentiation, and by function examining the
permeability barrier using transepidermal water loss (TEWL). No gross epidermal phenotype was observed;
however, immunocytochemical assessment of the epidermis revealed a reduction in involucrin, ﬁlaggrin, and
loricrin—markers of differentiation in the keratinocyte and critical for the formation of the corniﬁed envelope. These
observations were conﬁrmed at the electron microscopic level, which showed a reduction in the F (containing
ﬁlaggrin) and L (containing loricrin) granules and a reduced calcium gradient. The functional signiﬁcance of these
observations was tested using TEWL to evaluate the permeability barrier function of the epidermis. Although TEWL
was normal in the basal state, following disruption of the barrier using tape stripping, the 1aOHase/ animals
displayed a markedly delayed recovery of normal barrier function. This delay was associated with a reduction in
lamellar body secretion and a failure to reform the epidermal calcium gradient. Thus, the 25OHD 1OHase is
essential for normal epidermal differentiation, most likely by producing the vitamin D metabolite, 1,25(OH)2D,
responsible for inducing the proteins regulating calcium levels in the epidermis that are critical for the generation
and maintenance of the barrier.
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Keratinocytes are not only capable of producing vitamin D3
from endogenous sources of 7-dehydro-cholesterol (7-
DHC) in a regulated fashion but of metabolizing vitamin D
via 25 hydroxylation and 1a-hydroxylation to 1,25(OH)2D
(Bikle et al, 1986a, b; Matsumoto et al, 1991; Lehmann et al,
2001). Thus, keratinocytes are the only cells in the body with
the whole pathway from 7-DHC to 1,25(OH)2D. The vitamin
D-25 hydroxylase in keratinocytes is the same mitochon-
drial enzyme (CYP27) that converts vitamin D to 25OHD in
the liver (Lehmann et al, 1999). Similarly, the 25OHD-1a
hydroxylase (1OHase) in the epidermis, which is responsible
for 1,25(OH)2D production, is the same enzyme (CYP27B1)
as in the kidney (Fu et al, 1997). The expression and
enzymatic activity of 1OHase in keratinocytes are tightly
regulated and coupled to the differentiation of these cells
(Pillai et al, 1988a).
The observation that 1,25(OH)2D induces keratinocyte
differentiation in vitro was made by Hosomi et al (1983) and
provided a rationale for the previous and unexpected
finding of 1,25(OH)2D receptors in the epidermis in vivo
(Stumpf et al, 1979). 1,25(OH)2D is likely to be an autocrine
or paracrine factor for epidermal differentiation since it is
produced by the keratinocyte, but under normal circum-
stances keratinocyte production of 1,25(OH)2D contributes
minimally to circulating levels (Bikle et al, 1986a, b). The
receptors (vitamin D receptor (VDR)) for and the production
of 1,25(OH)2D vary with differentiation (Horiuchi et al, 1985,
Merke et al, 1985, Pillai et al, 1988a) in a manner that
suggests feedback regulation; i.e., VDR and 1OHase are
found in highest levels in the stratum basale in vivo and both
are reduced with differentiation of keratinocytes in vitro. In
vitro 1,25(OH)2D induces involucrin and transglutaminase,
and stimulates cornified envelope formation at subnano-
molar concentrations in preconfluent keratinocytes (Hosomi
et al, 1983; Smith et al, 1986; McLane et al, 1990; Pillai and
Bikle, 1991; Su et al, 1994). Where examined, these effects
of 1,25(OH)2D could be reproduced by 25OHD (Bikle et al,
1991; Matsumoto et al, 1991), presumably because of
Abbreviations: 1,25(OH)2D, 1,25-dihydroxyvitamin D; 25OHD, 25
hydroxyvitamin D; 1OHase, 25OHD 1a-hydroxylase; TEWL, trans-
epidermal water loss; VDR, vitamin D receptor
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endogenous conversion of 25OHD to 1,25(OH)2D, but are
not observed with the biologically inactive b isomer of
1,25(OH)2D (Smith et al, 1986) (the natural isomer is
la,25(OH)2D) indicating specificity for the natural metabolite
of 1OHase. Thus, 1,25(OH)2D and the enzyme that
produces it are likely to play an important role in epidermal
differentiation in vivo as well as in vitro, the hypothesis being
tested in this study.
Calcium is the best-studied prodifferentiating agent for
keratinocytes. As for 1,25(OH)2D, most of these studies
have been performed in vitro. But a calcium gradient exists
in the epidermis with low levels of calcium in the basal and
spinous layers but with substantially higher levels of calcium
in the upper granular layers, accumulating in the cytoplasm
and the intercellular matrix (Menon et al, 1985). This
gradient of calcium appears to provide the driving force
for differentiation in intact epidermis (Elias et al, 2002).
Calcium and 1,25(OH)2D interact in their ability to
stimulate differentiation (Su et al, 1994). Both calcium (in
the absence of 1,25(OH)2D) and 1,25(OH)2D (at 0.03 mM
Ca2þ ) raise the mRNA levels for involucrin and transgluta-
minase in a concentration-dependent fashion. The stimula-
tion is synergistic at intermediate concentrations of calcium
(0.1 mM) and 1,25(OH)2D (10
10 M), but inhibition is
observed in combination at higher concentrations because
mRNA stability decreases (Su et al, 1994).
The recent availability of mice lacking the 1OHase
(1aOHase/) (Dardenne et al, 2001; Panda et al, 2001)
provides an opportunity to evaluate the degree to which
1,25(OH)2D and its epidermal production are required for
epidermal differentiation in vivo. We report here that these
mice show a reduction in levels of proteins forming the
corneocyte associated with a marked reduction in intrae-
pidermal calcium. Furthermore, 1aOHase/ animals have
a retarded recovery of permeability barrier function after
acute disruption of the stratum corneum, associated with an
impaired reestablishment of the calcium gradient in the
epidermis. Unlike VDR/ mice, 1aOHase/ mice do not
have a defect in hair follicle cycling. These observations
indicate that endogenously produced 1,25(OH)2D and/or
1OHase are critical for normal epidermal differentiation,
perhaps by facilitating the formation and maintenance of the
calcium gradient.
Results
General appearance is little affected The 1aOHase/
mice demonstrated little difference in gross phenotype over
the first 6 wk of life. Body size and weight gain were not
significantly different from their wild-type littermates during
this period regardless of whether the mice were maintained
on the 1.3% calcium diet or the 2.4% calcium rescue diet.
Only after 6 wk were differences in body size observed in
the 1aOHase/ animals on the 1.3% diet, although the 2%
calcium rescue diet prevented any decline in growth rate. At
no time was alopecia observed.
Reduced expression of markers of differentiation in
the epidermis of 1aOHase/ mice In vitro, 1,25(OH)2D
reduces keratinocyte proliferation, while inducing the
expression of differentiation markers and promoting corni-
fied envelope formation. In the 1aOHase/ mouse epider-
mis, hyperplasia was not observed, nor were differences in
the epidermal expression of the PCNA found at any age
between wild-type and 1aOHase/ mice (data not shown).
But when the expression of differentiation markers in the
epidermis was evaluated by immunocytochemistry, a
decrease in the levels of filaggrin, loricrin, and involucrin
was observed in 1aOHase/ mice (Fig 1). These differ-
ences were apparent by 1 wk of age and persisted
throughout the 6 wk study. The reduction in expression of
these differentiation markers was accompanied by a
reduction in the number of keratohyalin granules in the
upper layers (stratum granulosum) of the epidermis (Fig 1).
Electron microscopic examination of the epidermis of the
1aOHase/ mice confirmed the marked reduction in both
the F-type (filaggrin-containing) and L-type (loricrin-contain-
ing) granules (Fig 2).
Barrier function is abnormal in 1aOHase/ mice The
barrier to water loss is a critical feature of the terminal
differentiation of the epidermis. In the resting (basal) state,
TEWL rates were comparable in the 1aOHase/ mice and
their wild-type littermates. But the 1aOHase/ mice
showed a marked retardation in the recovery of the barrier
following acute disruption (Fig 3). In particular, 3 h after
barrier disruption the wild-type mice had recovered 55% of
the baseline value, with a further recovery to 65% of the
basal value by 6 h, whereas the 1aOHase/ mice had
recovered only 27% of the baseline value by 3 h, with little
or no further improvement by 6 h.
Lamellar body secretion is abnormal in the epidermis of
1aOHase/ mice following barrier disruption Following
barrier disruption, the cells in the stratum granulosum
normally accelerate the secretion of their contents of
lamellar bodies into the intercellular space between the
stratum granulosum and stratum corneum, a process that
leads to rapid restoration of normal barrier function. To
ascertain whether reduced lamellar body secretion con-
tributed to the delay in barrier recovery in 1aOHase/ mice,
we examined the ultrastructure of the outer layers of the
epidermis from 1aOHase/ mice and their wild-type
littermates 3 h after barrier disruption (Fig 4). Reduced
lamellar body contents were present at the stratum
corneum–stratum granulosum interface of the epidermis of
1aOHase/ mice compared with that of wild-type mice
(compare Fig 4A and B to Fig 4C and D). Note again the
reduction in both F and L granules in the epidermis of the
1aOHase/ mice compared with that in wild-type mice.
The reduction in lamellar body secretion correlates with and
explains the delay in barrier recovery in the 1aOHase/
mice.
Epidermal calcium gradient is reduced in 1aOHase/
mice 1,25(OH)2D increases the calcium levels of keratino-
cytes in vitro, an effect thought to be critical for its ability to
stimulate differentiation. Similarly, the epidermis displays a
calcium gradient, with low levels of calcium in the basal and
spinous layers, but increased levels in the granular layer,
peaking just under the stratum corneum. The calcium
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gradient in the epidermis in vivo is associated with the
maintenance of barrier function by two mechanisms. First, it
regulates lamellar body secretion, and, second, it appears
to play a critical role in the induction of proteins required for
cornified envelope formation. As shown in Figs 2 and 4 both
lamellar body secretion and levels of corneocyte proteins
are reduced in the epidermis of 1aOHase/ mice. There-
fore, we next examined the calcium gradient in the
epidermis of the 1aOHase/ mice compared with that of
their wild-type littermates (Fig 5). In the basal state, the
levels of calcium in the outer epidermis of 1aOHase/ mice
were reduced overall, with little evidence of a gradient from
the stratum basale to the stratum granulosum as was found
in wild-type mice (compare Fig 5A to Fig 5C). Moreover,
some sections of the 1aOHase/ epidermis showed
increased calcium in the stratum corneum (Fig 5B)
consistent with an abnormality in barrier function.
To determine whether the delay in permeability barrier
recovery in the 1aOHase/ mouse correlated with an
abnormal recovery of the calcium gradient following barrier
disruption, we examined the calcium gradient at different
times after acute barrier disruption (Fig 6). Immediately after
barrier disruption, calcium levels in the epidermis of both
wild-type and 1aOHase/ mice became negligible, with
loss of the gradient (compare Fig 6A to Fig 6C); however, by
6 h the calcium gradient was well on its way to restoration in
wild-type animals, but was not in 1aOHase/ mice
(compare Fig 6B to Fig 6D). These results suggest that
endogenous 1,25(OH)2D production influences the forma-
tion of the epidermal calcium gradient, and in the absence
of this gradient the rate of recovery of barrier function
following perturbation is impaired.
Discussion
The discovery of high levels of 1OHase activity in the
keratinocyte was a well-documented early example of
extrarenal 1,25(OH)2D production (Bikle et al, 1986a, b).
But the actual requirement for this enzyme or its product,
Figure 1
Decreased levels of filaggrin, loricrin,
and involucrin in the 1aOHase/
mouse. Representative sections of the
skin from the backs of 2-wk-old wild-
type and 1aOHase/ mice (n¼ 3 per
group) were assessed by immunocyto-
chemistry for the expression of filaggrin
(Fil), loricrin (Lor), and involucrin (Inv). As
expected these proteins were ex-
pressed primarily in the outer layers of
the epidermis. Expression was substan-
tially lower in the epidermis of the
1aOHase/ mice. Note also the marked
reduction in granules in the outer epi-
dermis of the 1aOHase/ mice.
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1,25(OH)2D, in epidermal function has not been clarified.
In vitro studies performed in the absence of serum, and
so in the absence of vitamin D and its metabolites, have
indicated that 1,25(OH)2D is not required for calcium-
induced differentiation (Pillai et al, 1988b), although
1,25(OH)2D clearly influences the differentiation process
by itself and in coordination with calcium (Hosomi et al,
1983; Smith et al, 1986; McLane et al, 1990; Pillai and Bikle,
1991; Su et al, 1994). Furthermore, in humans with
mutations in 1aOHase no striking epidermal phenotype
has been described, although this has not been examined
in detail. Conceivably, calcium and other regulators of
differentiation can compensate to a large degree for the lack
of 1,25(OH)2D. The lack of apparent epidermal phenotype in
these subjects contrasts with the alopecia and prominent
skin changes seen in humans and mice with mutations in
the vitamin D receptor gene (Vdr) (Marx et al, 1986; Li et al,
1997; Xie et al, 2002). Thus, one might conclude that
1,25(OH)2D has at best a modulating influence on calcium-
regulated epidermal differentiation, and in its absence other
factors sufficiently compensate so as to preserve a normal
phenotype. These studies with the 1aOHase/ mouse call
this conclusion into question.
The role of 1,25(OH)2D in regulating calcium transport is
well established in calcium-transporting cells such as
the intestinal epithelial cell (Bikle 1990). 1,25(OH)2D also
regulates calcium signaling by non-calcium-transporting
cells such as the keratinocyte by inducing the calcium
receptor (Ratnam et al, 1999; Tu et al, 2001) and the
phospholipase C and D families (Pillai et al, 1995; Griner
et al, 1999), proteins essential for calcium-regulated
differentiation. 1,25(OH)2D increases intracellular calcium
in vitro and accelerates differentiation as assessed by
increased expression of involucrin and transglutaminase
and stimulated cornified envelope formation (McLane et al,
1990; Pillai and Bikle, 1991). Our results in vivo suggest a
similar role for 1,25(OH)2D in that the gradient of calcium
seen in normal epidermis does not form in the epidermis of
mice lacking 1OHase. Disruption of the barrier in vivo by
tape stripping or acetone results in loss of calcium from the
outer epidermis (Mao-Qiang et al, 1997) and increased
secretion of a preformed pool of lamellar bodies into the
stratum corneum/stratum granulosum junction. This abrupt
loss of calcium stimulates lamellar body secretion, leading
to restoration of the permeability barrier and the calcium
gradient (Menon et al, 1992, 1994). Furthermore, the loss of
calcium from the stratum granulosum immediately after
Figure 2
Decreased granules in the outer epidermis in 1aOHase/ mice. Electron micrographs of representative sections of the epidermis from skin
samples taken from the backs of 6-wk-old 1aOHase/ mice and their wild-type littermates (n¼3 per group) demonstrate a marked reduction in
number and size of loricrin and keratohyalin granules in the outer epidermis of the 1aOHase/ mice. These findings are consistent with the
reduction in loricrin and filaggrin demonstrated in Fig 1.
Figure 3
Barrier recovery is delayed in 1aOHase/ mice. The permeability
barrier of the epidermis was disrupted by tape stripping. Transepider-
mal water loss (TEWL) was measured prior to and 3 and 6 h after tape
stripping. The degree to which recovery of the barrier after tape
stripping is achieved at these time points is recorded. Eleven
1aOHase/ mice and 12 wild-type mice, ages 6–7 wk, were used in
this experiment. At both the 3 and 6 h time points, recovery of barrier
function was significantly delayed in 1aOHase/ mice. The error bars
enclose mean  SD.
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barrier disruption leads to a transient decrease in expres-
sion of the differentiation markers loricrin, profilaggrin,
and involucrin (Elias et al, 2002) suggesting that calcium
regulates their expression in vivo as well as in vitro.
In this study, we compared 1aOHase/ mice compared
with their wild-type littermates to determine whether
1OHase activity was required for normal differentiation of
keratinocytes in vivo. Although there was no striking gross
phenotype in 1aOHase/ mice, the levels of the differ-
entiation markers involucrin, profilaggrin, and loricrin were
reduced. This reduction was associated with a reduction of
calcium in the outer layers of the epidermis, consistent with
the observations in vitro that increased intracellular calcium
regulates the expression of these genes. Although we did
not find a difference in barrier function in the basal state
between 1aOHase/ mice and their wild-type littermates,
we observed a pronounced retardation in the ability of
1aOHase/ mice to recover normal barrier function
following acute perturbation. This barrier abnormality
identified functionally as increased TEWL was shown
morphologically to correlate with decreased lamellar body
secretion and failure of the calcium gradient to form after
barrier disruption in 1aOHase/ mice. Placing the animals
on a high-calcium diet previously shown to normalize serum
Figure 4
1aOHase/ mice have a reduced
secretion of lamellar body content
into the stratum corneum/stratum
granulosum junction following barrier
disruption. Skin samples from the
backs of 1aOHase/ mice and their
wild-type littermates (n¼ 3 per group)
were processed for electron microscopy
3 h after tape stripping to break the
permeability barrier. The epidermis from
1aOHase/ mice (A, B) showed a
marked reduction in the amount of
osmiphilic material in the intercellular
space between the cells of the stratum
corneum and stratum granulosum (open
arrowheads) following tape stripping
compared with their wild-type litter-
mates (C, D) (large closed arrowheads).
Note also the reduced number of kera-
tohyalin granules in the epidermis of the
1aOHase/ mice (A, B compared with
D) (small arrowheads).
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calcium and correct the rickets in these mice (Dardenne
et al, 2003) did not normalize these findings (data not
shown). Similarly, we were not able to correct the abnormal-
ity in the calcium gradient or the delay in permeability barrier
recovery by exogenous 1,25(OH)2D application (data not
shown). As previously shown by von Brenken et al (1997),
topical application of 1,25(OH)2D to mouse skin increased
TEWL (i.e., decreased permeability barrier function),
whereas systemic administration had little effect (data not
shown), suggesting either that the site and mode of delivery
of 1,25(OH)2D to the epidermis (autocrine/paracrine versus
exogenous) is critical for its actions or that 1OHase has a
function other than 1,25(OH)2D production that influences
epidermal differentiation and permeability barrier formation.
Although the reduction in levels of corneocyte proteins is
consistent with the lack of 1,25(OH)2D and calcium in the
epidermis, the reduction in lamellar body secretion in the
1aOHase/ mice is somewhat paradoxical in that the loss
of the calcium gradient in normal epidermis following barrier
disruption results in increased lamellar body secretion.
Thus, one might anticipate that lamellar body secretion
would be increased in the 1aOHase/ mice lacking a
normal calcium gradient. Conceivably, however, it is the rate
of calcium flux out of the keratinocyte at the time of barrier
disruption that stimulates lamellar body secretion, and this
rate would be reduced in keratinocytes from the 1aOHase/
mouse that have little calcium in their stratum granulosum.
Alternatively, 1,25(OH)2D may regulate lamellar body secre-
tion and/or formation independent of its effects on the
calcium gradient.
We conclude from these observations that the 1OHase
produces a product, presumably 1,25(OH)2D, that plays an
important role in calcium handling by the keratinocyte both
in vivo and in vitro. In vivo, the lack of this activity leads to a
reduction in calcium in the stratum granulosum, a failure to
respond appropriately to barrier disruption with restoration
of the barrier, and decreased expression of markers of
differentiation. In the basal state, compensatory mechan-
isms appear sufficient to maintain a normal barrier despite a
reduced calcium gradient and reduced levels of the
differentiation markers; however; one might predict from
these observations that disruption of the barrier would have
greater pathologic consequences in the human or mouse
with 1aOHase deficiency than in normal animals.
Materials and Methods
Animals Mice heterozygous for the 1aOHase null mutation,
1aOHase/þ , outbred to C57BL/6 as previously described
(Dardenne et al, 2001), were bred to provide wild-type
(1aOHaseþ /þ ) and homozygous mutant 1aOHase/ littermates
used for these studies. Genotyping was performed by PCR.
Figure 5
The calcium gradient is reduced in
the epidermis of 1aOHase/ mice.
Skin samples from the backs of
1aOHase/ mice and their wild-type
littermates (n¼3 per group) were pro-
cessed by ion capture cytochemistry to
detect calcium in the epidermis. The
1aOHase/ mice (A, B) have substan-
tially less calcium in their epidermis than
do wild-type mice (C), and no obvious
gradient of calcium is seen from the
stratum basale to the stratum granulo-
sum in 1aOHase/ mice unlike their
wild-type littermates. In some sections
of skin from the 1aOHas/ mice,
increased calcium in the stratum cor-
neum was observed (B).
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Primers used for PCR include an upper primer (50-CCCATCCCGA-
GAACTCTA-30) and a lower primer (50-GTGCCGTGATAAATGCTT-
30) that encompass the deleted exon 8 in the mutant 1aOHase
allele. After weaning, the mice were raised on a 1.3% calcium,
1.03% phosphorus diet (Teklad diet 8656, Harlan Teklad, Madison,
Wisconsin) or on a 2% calcium, 1.25% phosphorus, 20% lactose
diet (rescue diet) (TD96348, Teklad) shown previously to normalize
mineral ion homeostasis and prevent rickets in these mice
(Dardenne et al, 2003). Results were comparable between the
two diets, so the data shown will be from mice on the lower
calcium diet. These studies were approved by the Animal use
Committee of the San Francisco Veterans Affairs Medical Center.
Assessment of barrier function and its recovery after pertur-
bation For studies of barrier function, the backs of mice were
shaved 24 h prior to the determination of transepidermal water loss
(TEWL) as previously described (Grubauer et al, 1989). The barrier
was disrupted by cellophane tape stripping until TEWL levels were
4 mg per cm2 per h, and measurements of TEWL repeated at 3 and
6 h following tape stripping. Samples of skin were also obtained for
electron microscopy and calcium gradient determinations prior to
and immediately following barrier disruption as well as 3 and 6 h
later to evaluate recovery. All studies were approved by the Animal
Use Committee at the Veterans Affairs Medical Center, San
Francisco.
Immunohistochemistry The skin from the upper portion of the
back was excised and fixed with 4% formaldehyde (freshly
prepared from paraformaldehyde) in phosphate-buffered saline at
41C for 12 h, then embedded in paraffin. The paraffin-embedded
tissues were cut into 5 mm sections. After deparaffinization and
rehydration, the sections were boiled in 10 mM citrate buffer
for 20 min. Endogenous peroxidase activity was quenched with
3% hydrogen peroxide in methanol for 15 min. The sections
were then incubated with 4% bovine serum albumin in Tris-
buffered saline for 30 min to block non-specific binding. To assess
proliferation, a monoclonal biotinylated proliferating cell nuclear
antigen (PCNA) antibody (to detect proliferating cells) (CalTag,
Figure 6
Response of the calcium gradient to
barrier disruption. The stratum cor-
neum was removed by tape stripping
to disrupt the barrier. Immediately fol-
lowing barrier disruption, calcium was
lost from the outer epidermis in all mice
(A, C); however, 1aOHase/ mice (B)
failed to regain calcium by 6 h, whereas
wild-type mice did (D). These sections
are representative of samples taken from
three wild-type and three 1aOHase/
mice at each time point.
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South San Francisco, California) was used. To assess differentia-
tion, affinity-purified rabbit antipeptide antibodies (BabCo, Berke-
ley, California) specific for involucrin, loricrin, and filaggrin were
used. The primary antibodies were used at a concentration of 4 mg
per mL. All the immunoreagents were diluted in 10 mM Tris buffer,
pH 7.6, containing 4% bovine serum albumin, 1% teleostean skin
gelatin, 0.1% Tween 20, and 500 mM NaCl. The binding of the
primary antibodies to the sections was detected by affinity-
purified, biotinylated goat anti-rabbit IgG, followed by ABC-
peroxidase reagent, both purchased from Vector (Burlingame,
California). Peroxidase activity was revealed with DAB substrate
(QualTek Laboratories, Santa Barbara, California) followed by
counterstaining with methyl green or hematoxylin. Omitting the
first antibodies resulted in no signal, indicating the specificity of
immunodetection. Sections were then counterstained with hema-
toxylin. The level of expression of the differentiation markers in the
sections was then scored by the three senior authors (D. D. B., K.
F., P. M. E.), who were blinded as to genotype.
Electron microscopy Skin samples from 6-wk-old wild-type
(1aOHaseþ /þ ) and homozygous mutant 1aOHase/ littermates
were prepared according to previously reported procedures (Yu
et al, 1996). Briefly, they were fixed in 2.5% glutaraldehyde, post-
fixed with 1% reduced osmium tetroxide, dehydrated in a graded
ethanol series, and embedded in an Epon mixture. Ultrathin
sections were cut with a diamond knife, double stained with uranyl
acetate and lead citrate, and examined in a Zeiss 10A electron
microscope (Carl Zeiss Microimaging, Thornwood, NY) operated at
60 kV. In each section, the entire area of the granular layer was
examined, and representative images were photographed for
analysis. Micrographs were then coded and examined by two
observers blinded with respect to treatment or genotype.
Assessment of epidermal calcium gradient Skin samples were
removed and processed for ion-capture cytochemistry, as pre-
viously described (Menon et al, 1985). Samples were minced and
immediately immersed in an ice-cold fixative containing 2%
glutaraldehyde, 2% formaldehyde, 90 mM potassium oxalate,
and 1.4% sucrose, pH 7.4. After overnight fixation at 41C in the
dark, samples were post-fixed in 1% osmium tetroxide containing
2% potassium pyroantimonate at 41C in the dark for 2 h, rinsed in
cold distilled water (adjusted to pH 10 with KOH), and routinely
processed, embedded, and sectioned as above. Ultrathin sections
were examined without further processing in a Zeiss electron
microscope operating at 60 kV. Micrographs were coded and
evaluated as above.
Statistical analysis Statistical comparisons were made using
Student’s t test. Where more than two groups were compared,
ANOVA was also employed.
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